Hasil Pencarian  ::  Simpan CSV :: Kembali

"Skripsi ini membahas pelaksanaan pengetatan remisi narapidana korupsi di Lapas Sukamiskin Bandung pasca uji materiil Peraturan Pemerintah No. 99 Tahun 2012 tentang Perubahan Kedua Atas Peraturan Pemerintah Nomor 32 Tahun 1999 tentang Syarat dan Tata Cara Pelaksanaan Hak Warga Binaan Pemasyarakatan di Mahkamah Agung dan uji materiil Undang-Undang No. 12 Tahun 1995 tentang Pemasyarakatan di Mahkamah Konstitusi yang diajukan narapidana korupsi.Penelitian ini adalah penelitian yuridis normatif dengan pendekatan kualitatif untuk menganalisis pelaksanaan pengetatan remisi narapidana korupsi di Lapas Sukamiskin Bandung pasca uji materiil di Mahkamah Agung dan Mahkamah Konstitusi. Berdasarkan hasil penelitian yang dilakukan, pengetatan remisi narapidana korupsi yang diatur dalam PP 99 Tahun 2012 oleh narapidana korupsi dinilai bertentangan dengan hak-hak narapidana yang diatur dalam UU Pemasyarakatan. Setelah langkah uji materiil dilakukan narapidana korupsi di Mahkamah Agung dan Mahkamah Konstitusi ditolak, maka pelaksanaan pengetatan remisi narapidana korupsi di Lapas Sukamiskin Bandung dilakukan berdasarkan aturan perundang-undangan yang berlaku. Dari 366 narapidana korupsi di Lapas Sukamiskin, hanya 36 orang narapidana yang mendapatkan remisi. Sebanyak 30 orang mendapatkan remisi sebelum keluarnya PP 99 Tahun 2012 sehingga mereka tidak dikenai pengetatan syarat remisi. Sedangkan hanya 6 orang yang mendapatkan remisi pasca pengetatan yang diatur dalam PP. 99 Tahun2012 yaitu memenuhi syarat menjadi justice collaborator dan membayar lunas denda dan uang pengganti.

---

This thesis discuss the implementation of the tightening of remission for corruption prisoners at Sukamiskin Prison after material review in the Supreme Court against Government Regulation Number 99 Year 2012 on the Second Amendment of Government Regulation Number 32 Year 1999 on Conditions and Mechanisms for the Implementation of the Rights of Prisoners (PP 99 Year 2012) and another material review submitted by corruption prisoners in the Constitutional Court against Law Number 12 Year 19995 on Correction (Correction Law). The nature of the research is normative juridical with qualitative approve to analyze the implementation of tightening remission for remission for corruption prisoners at Sukamiskin Prison after those material reviews in the Supreme Court and the Constitutional Court. The result of this research shows that in the view of corruption prisoners the policy to tighten remission for corruption prisoners regulated in PP 99 Year 2012 contradicts with the rights of the prisoners regulated in the Correction Law. After both material reviews in the Supreme Court and in the Constitutional Court has failed, the policy of the tightening remission for corruption prisoners at Sukamiskin Prison in Bandung is implemented according to the applied rules and regulations. Out of 366 corruption prisoners at Sukamiskin Prison, there are only 36 prisoners who have received remission. However, 30 prisoners received the remission before PP 99 Year 2012 being issued so that the tightening remission policy was not applied for them. Meanwhile, only 6 prisoners were able to receive remission after the tightening policy in PP 99 Year 2012 was implemented, because they were qualified as justice collaborators and has paid fine penalties as well as fine replacements."

"Doksorubisin adalah antibiotik golongan antrasiklin yang digunakan sebagai agen antikanker. Doksorubisin merupakan salah satu terapi antikanker lini pertama yang memiliki aktivitas klinis pada penyakit kanker payudara. Doksorubisin dimetabolisme menjadi doksorubisinol sebagai metabolit utama. Pada penggunaannya, doksorubisin memberikan beberapa efek samping akibat terbentuknya doksorubisinol. Akumulasi doksorubisinol jangka panjang dalam tubuh dapat menyebabkan kardiomiopati, atau lemah jantung, karena doksorubisinol bersifat kardiotoksik. Efek kardiotoksik ini bergantung pada jumlah doksorubisin dan doksorubisinol yang terbentuk dalam tubuh. Penelitian ini bertujuan untuk menganalisis doksorubisin dan doksorubisinol yang terbentuk dalam tubuh pasien kanker payudara. Partisipan penelitian ini adalah tiga puluh pasien kanker payudara yang menggunakan doksorubisin dalam regimen terapinya. Sampel dianalisis menggunakan Kromatografi Cair Kinerja Ultra Tinggi-Tandem Spektrometri Massa (KCKUT-SM/SM). Preparasi sampel plasma darah sebanyak 250 mL dilakukan menggunakan pengendapan protein dengan metanol. Fase gerak terdiri dari asam asetat 0,1% (eluen A) dan asetonitril (eluen B) dengan elusi gradien, laju alir 0,15 mL/menit. Metode ini linier pada rentang 1-1000 ng/mL untuk doksorubisin dan 0,5-500 ng/mL untuk doksorubisinol. Analisis sampel menghasilkan data berupa rentang kadar terukur untuk doksorubisin sebesar 12,54-620,01 ng/mL serta doksorubisinol sebesar 1,10-27,00 ng/mL. Dosis kumulatif pada pasien untuk doksorubisin memiliki rentang 48,76-290,34 mg/m2, sehingga dapat disimpulkan risiko pasien pada penelitian ini terkena kardiomiopati berada di bawah angka kejadian 4% menurut literatur.

---

Doxorubicin was an anthracycline antibiotic used for anticancer agent. This anticancer agent was one of the first line anticancer therapies which had clinical activity in breast cancer. Doxorubicin was metabolized in the body into its main metabolite, doxorubicinol. The metabolite and caused cardiomyopathy, or hearts failure, due to its cardiotoxicity. This cardiotoxicity effect depended on the amount of doxorubicin and doxorubicinol accumulated in the body. This study aimed to analysis the level of doxorubicin and doxorubicinol in the blood plasma of breast cancer patients. Participants of this study were 30 breast cancer patients who received doxorubicin in their therapy regiment. The samples were analyzed using Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS). Sample preparation of 250 mL plasma was performed by protein precipitation using methanol. The mobile phase consisted of acetate acid 0,1% (eluent A) and acetonitrile (eluent B) with gradient elution, and the flow rate of 0,15 mL/min. This method was linear in the range of 1-1000 ng/mL for doxorubicin and 0,5-500 ng/mL for. Results showed that the measured concentration values of doxorubicin and doxorubicinol ranged between 12,54-620,01 ng/mL and 1,10-27,00 ng/mL respectively. The measured cumulative doses of doxorubicin ranged between 48,76-290,34 mg/m2, thus the risk of cardiomyopathy in the surveyed patients was under 4% according to the literature."

"

Dalam industri minyak dan gas, korosi yang diakibatkan oleh karbon dioksida masih menjadi tantangan yang besar yang dapat menyebabkan kegagalan material. Penelitian ini menggunakan salah satu turunan dari senyawa piridin sebagai inhibitor yang dapat ditambahkan ke dalam sistem perpipaan untuk mengurangi laju korosi. Piridin ini diteliti dengan variasi konsentrasi, yaitu 25 ppm, 50 ppm, dan 75 ppm, serta variasi temepratur, yaitu 40° dan 90°C. Pengujian Fourier Transform Infrared Spectroscopy (FTIR) dan Gas Chromatography – Mass Spectrometry (GCMS) dilakukan untuk mengkarakterisasi inhibitor, dimana ditemukan bahwa inhibitor ini memiliki molekul dengan heteroatom nitrogen yang dapat memfasilitasi proses adsorpsi. Efisiensi inhibisi korosi juga diukur menggunakan metode polarisasi linear dan Electrochemical Impedance Spectroscopy (EIS), dimana ditemukan bahwa laju korosi menurun dengan meningkatnya konsentrasi inhibitor dan meningkat dengan meningkatnya temperatur. Data dari pengujian elektrokimia juga digunakan untuk menentukan model adsorpsi isoterm dan tipe adsorpsi, dimana ditemukan bahwa model adsorpsi yang didapat adalah adsorpsi isoterm Langmuir dengan tipe adsorpsi campuran fisika dan kimia. Morfologi permukaan sampel juga diteliti menggunakan Scanning Electron Microscopy (SEM) dan Energy Dispersive X-Ray (EDX) dan hasilnya menunjukkan bahwa sebelum diberikan inhibitor, produk korosi mendominasi permukaan dan jumlahnya menurun secara drastis setelah inhibitor diberikan, menandakan bahwa inhibitor ini telah sukses untuk menurunkan laju korosi baja karbon pada lingkungan CO₂.

 

---

In oil and gas industry, corrosion caused by carbon dioxide is one of the greatest challenges that could lead to material failure. This research uses a derivative of pyridine as an inhibitor that can be added to the piping system to reduce the rate of corrosion. Pyridine was examined with variations in concentration, namely 25 ppm, 50 ppm, and 75 ppm, as well as variations in temperature, namely 40° and 90°C. Fourier Transform Infrared Spectroscopy (FTIR) and Gas Chromatography - Mass Spectrometry (GCMS) tests were performed to characterize the inhibitors, which found that these inhibitors have molecules with nitrogen heteroatoms that can facilitate the adsorption process. The efficiency of corrosion inhibition was also measured using the potentiodynamic polarization method and Electrochemical Impedance Spectroscopy (EIS), which found that the corrosion rate decreased with increasing inhibitor concentration up to an optimal concentration of 50 ppm and increased with increasing temperature. The data from electrochemical testing was also used to determine the adsorption model of the isotherm and the type of adsorption, and it was found that the adsorption in this system obeyed Langmuir isotherm adsorption and is governed by a mixture of physical and chemical type. The surface morphology of the samples was also investigated using Scanning Electron Microscopy (SEM) and Energy Dispersive X-Ray (EDS) and the results showed that before injected with inhibitors, corrosion products dominated the surface and the amount decreased dramatically after the inhibitor was given, indicating that this inhibitor was successful to reduce the rate of carbon steel corrosion in the CO₂ environment.

"

"With chapters provided by international leading experts, this book covers the recent advances in protein and peptide mass spectrometry. Focusing on the pharmaceutical industry, it addresses both emerging techniques, including imaging mass spectrometry, ion mobility, and microwave-assisted mass spectrometry, and recent applications, including pharmaceutical analysis throughout the drug development cycle. The book stresses practice and applications, providing real world examples from industry contributors. After overviewing methodology and discussing recent studies, the remaining chapters address newer techniques for determining protein structure, interactions with peptides, proteins, and ligands, and protein folding and unfolding."

"ABSTRAKLerkanidipin adalah antihipertensi generasi ketiga dari penghambat kanal kalsium(antagonis kalsium) golongan dihidropiridin. Obat ini efektif dalam pengobatan pasiendengan hipertensi ringan sampai sedang tanpa mempengaruhi denyut jantung. Sebagai obatyang digunakan dalam kondisi serius, obat ini perlu dilakukan uji bioekivalensi sehinggaperlu dikembangkan metode bioanalisis yang handal, cepat, dan memiliki sensitivitas yangtinggi. Oleh karena itu penelitian ini bertujuan untuk memperoleh metode yang optimumdan tervalidasi untuk menganalisis lerkanidipin dalam plasma menggunakan KromatografiCair Kinerja Ultra Tinggi tandem Spektrometri Massa (KCKUT-SM/SM). Pemisahandilakukan menggunakan kolom Waters AcquityTM UPLC C18 1,7 μm (2,1 x 100 mm)dengan fase gerak berupa campuran asam format 0,1% - metanol (20:80 v/v) dengan elusiisokratik, suhu kolom 30 oC, laju alir 0,2 mL/menit dan menggunakan amlodipin sebagaibaku dalam. Deteksi massa dilakukan dengan Waters Xevo TQD tipe ElectrosprayIonization (ESI) positif pada mode Multiple Reaction Monitoring. Lerkanidipin terdeteksipada nilai m/z 612,11 > 280,27 dan amlodipin terdeteksi pada nilai m/z 409,1 > 238,15.Metode preparasi sampel yang optimum adalah metode ekstraksi cair-cair dengan 5 mLcampuran n-heksana ? etil asetat (50:50 v/v) sebagai pengekstraksi, pengocokan denganvorteks selama 3 menit, pemutaran dengan sentrifugasi 4000 rpm selama 20 menit,evaporasi dengan gas nitrogen suhu 50 oC selama 30 menit, serta direkonstitusi dengan 100μl fase gerak. Metode ini linear pada rentang 0,025 ? 10 ng/mL dengan r ≥ 0,9986. Akurasidan presisi secara intra hari dan antar hari memenuhi persyaratan dengan nilai % diff dan %KV tidak melebihi ± 15% dan tidak lebih dari ± 20% untuk konsentrasi LLOQ. Selain itu,metode ini memenuhi persyaratan selektivitas, carry over, stabilitas, integritas pengenceran,dan efek matriks sesuai Guideline on Bioanalytical Method Validation oleh EuropeanMedicines Agency tahun 2011.

---

ABSTRACTFor the past five years, China?s economic growth has been increased significantly.However, public perception of the product from China is still not good. Based onthat problem, the objective of this research is to analyze the influence of the countryof origin towards the purchase intention. This research applied the quantitativeapproach with 100 respondents who have the willingness to buy the Xiaomi?ssmartphone, as the sample. The result of this research indicates that the country oforigin has a significant effect towards the purchase intention."

"

Madu sangat bermanfaat untuk tubuh. Madu dijadikan obat alternatif oleh masyarakat dalam menyembuhkan berbagai jenis penyakit dikarenakan kandungan senyawa di dalamnya. Tingginya permintaan pasar dikarenakan meningkatnya konsumsi madu oleh masyarakat memberikan peluang kepada oknum-oknum tidak bertanggung jawab untuk memalsukan madu. Oleh sebab itu diperlukan suatu teknologi canggih yang bisa mendeteksi keaslian madu beserta klasifikasikasi dan sifatnya secara cepat dan akurat. Identifikasi dan klasifikasi madu dilakukan pada madu asli yang berasal dari lebah Apis sp. dan juga stingless bees serta madu palsu buatan yang dibuat dengan percampuran madu asli dengan penambahan air gula (Fruktosa) dan NaHCO_3.  Dalam melakukan identifikasi madu dengan metode Artificial Neural Network (ANNs) digunakan software berupa MATLAB. Metode Artificial Neural Network (ANNs) yang digunakan adalah alogaritma backpropagation dengan arsitektur jaringan multilayer. Hasil dari peneitian ini adalah pengidentifikasian madu menggunakan metode Artificial Neural Network untuk percobaan 2 kelas memiliki hasil tranning dan testing yang lebih tinggi dibandingkan dengan percobaan dengan 6 kelas. Hal tersebut disebabkan karena semakin banyak kelas maka jumlah data setiap kelas harus semakin banyak dan sama rata dikarenakan jumlah data mempengaruhi hasil tranning dan testing dari Artificial Neural Network.

 

---

Honey is very beneficial for body. It can be used as an alternative medicine by humans for curing various types of diseases due to the compound contained in honey. The high market demand due to increasing consumption of honey by consumers provides opportunities for unscrupulous individuals to falsify honey. In order to prevent consumers from fake honey, we need a sophisticated technology that can detect the authenticity of honey along with its classification and nature quickly and accurately. In this study, a method for identifying and classifying the authenticity of honey using Artificial Intelligence (AI), the type of artificial intelligence that is used in this study is Artificial Neural Network (ANNs). The identification and classification of honey is performed using honey Apis sp bees, stingless bees and fake honey. Fake honey is made by adding sugar (Fructose) and NaHCO₃ to the honey. For identifying honey with the Artificial Neural Network (ANNs) method, the author used MATLAB software. The Artificial Neural Network (ANNs) method used is a backpropagation algorithm with multilayer network architecture. The result of this research is the identification of honey using the Artificial Neural Network method for the 2-class experiment which has higher tranning and testing results compared with experiments with 6 classes. This is because the amount of data per class must be more and equal because the amount of data affects the results of tranning and testing of Artificial Neural Network.

"

"Breakthroughs in combinatorial chemistry and molecular biology, as well as an overall industry trend toward accelerated development, mean the rate of sample generation now far exceeds the rate of sample analysis in the pursuit of producing new and better pharmaceuticals. LC/MS is an analytical tool that helps the researcher identify the most promising sample early in the selection process, effectively creating a shortcut to finding new drugs. This book is the first to describe LC/MS applications within the context of drug development, including the discovery, preclinical, clinical, and manufacturing phases. In addition to the thorough technical analysis of this tool, LC/MS Applications in Drug Development provides perspective on the significant changes in strategies for pharmaceutical analysis. A process overview of drug development from an analytical point of view is provided along with essential data required to successfully bring a drug to market. The incorporation of LC/MS is illustrated from target to product. Chapters pertaining to the discovery process itself include : proteomics, glycoprotein mapping, natural products dereplication, lead identification screening, open-access LC/MS, in vitro drug screening written for both the analytical chemist who uses LC/MS applications and the pharmaceutical scientist who works with the drugs they produce."